These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Tissue exposures to free and glucuronidated monobutylyphthalate in the pregnant and fetal rat following exposure to di-n-butylphthalate: evaluation with a PBPK model. Clewell RA, Kremer JJ, Williams CC, Campbell JL, Andersen ME, Borghoff SJ. Toxicol Sci; 2008 Jun; 103(2):241-59. PubMed ID: 18344531 [Abstract] [Full Text] [Related]
9. Metabolism and pharmacokinetics of bisphenol A (BPA) and the embryo-fetal distribution of BPA and BPA-monoglucuronide in CD Sprague-Dawley rats at three gestational stages. Domoradzki JY, Pottenger LH, Thornton CM, Hansen SC, Card TL, Markham DA, Dryzga MD, Shiotsuka RN, Waechter JM. Toxicol Sci; 2003 Nov 05; 76(1):21-34. PubMed ID: 12915710 [Abstract] [Full Text] [Related]
11. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice. Marsman D. Toxic Rep Ser; 1995 Apr 05; 30():1-G5. PubMed ID: 12209194 [Abstract] [Full Text] [Related]
12. Development and Validation of an Analytical Method for Quantitation of Monobutylphthalate, a Metabolite of Di-n-Butylphthalate, in Rat Plasma, Amniotic Fluid, Fetuses and Pups by UPLC-MS/MS. Silinski MAR, Fernando RA, Robinson VG, Waidyanatha S. J Anal Toxicol; 2020 May 18; 44(4):370-377. PubMed ID: 31776566 [Abstract] [Full Text] [Related]
13. Steady-State Human Pharmacokinetics of Monobutyl Phthalate Predicted by Physiologically Based Pharmacokinetic Modeling Using Single-Dose Data from Humanized-Liver Mice Orally Administered with Dibutyl Phthalate. Miura T, Uehara S, Mizuno S, Yoshizawa M, Murayama N, Kamiya Y, Shimizu M, Suemizu H, Yamazaki H. Chem Res Toxicol; 2019 Feb 18; 32(2):333-340. PubMed ID: 30652481 [Abstract] [Full Text] [Related]
14. Age and dose dependency of the pharmacokinetics and metabolism of bisphenol A in neonatal sprague-dawley rats following oral administration. Domoradzki JY, Thornton CM, Pottenger LH, Hansen SC, Card TL, Markham DA, Dryzga MD, Shiotsuka RN, Waechter JM. Toxicol Sci; 2004 Feb 18; 77(2):230-42. PubMed ID: 14691203 [Abstract] [Full Text] [Related]
16. Transplacental pharmacokinetics and fetal distribution of azidothymidine, its glucuronide, and phosphorylated metabolites in late-term rhesus macaques after maternal infusion. Patterson TA, Binienda ZK, Lipe GW, Gillam MP, Slikker W, Sandberg JA. Drug Metab Dispos; 1997 Apr 18; 25(4):453-9. PubMed ID: 9107545 [Abstract] [Full Text] [Related]
17. Differences in urinary metabolic profile from di-n-butyl phthalate-treated rats and hamsters. A possible explanation for species differences in susceptibility to testicular atrophy. Foster PM, Cook MW, Thomas LV, Walters DG, Gangolli SD. Drug Metab Dispos; 1983 Apr 18; 11(1):59-61. PubMed ID: 6132798 [Abstract] [Full Text] [Related]